A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients

The Pharmacogenomics Journal
S ChenChantal Guillemette

Abstract

The risk of severe irinotecan-induced neutropenia has been shown to be related to the UGT1 variant UGT1A1*28, which increases exposure to the potent metabolite SN-38. Our goal was to identify a novel UGT1 marker(s) using 28 haplotype-tagged single nucleotide polymorphisms genotyped by mass spectrometry. By characterizing the UGT1 sequence from a cohort of 167 Canadian metastatic colorectal cancer (mCRC) patients and a validation cohort of 250 Italian mCRC patients, we found rs11563250G, located in the intergenic region downstream of UGT1, to be significantly associated with reduced risk of severe neutropenia (odds ratio (OR)=0.21; P=0.043 and OR=0.27; P=0.036, respectively, and OR=0.31 when combined; P=0.001), which remained significant upon correction for multiple testing in the combined cohort (P=0.041). For the two-marker haplotype rs11563250G and UGT1A1*1 (rs8175347 TA6), the OR was of 0.17 (P=0.0004). Genetic testing of this marker may identify patients who might benefit from increased irinotecan dosing.

References

Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·E BeutlerA Demina
Mar 20, 2001·American Journal of Human Genetics·M StephensP Donnelly
Oct 24, 2003·American Journal of Human Genetics·Matthew Stephens, Peter Donnelly
May 3, 2005·Pharmacogenetics and Genomics·Federico InnocentiMark J Ratain
Jun 30, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hugo GirardChantal Guillemette
Nov 8, 2005·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Nicola F SmithAlex Sparreboom
Apr 6, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hugo GirardChantal Guillemette
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe ToffoliSergio Frustaci
Apr 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Erika CecchinGiuseppe Toffoli
May 6, 2009·Human Molecular Genetics·Andrew D JohnsonJacqueline C Witteman
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe ToffoliFederico Innocenti
Mar 26, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Zhe-Yi HuYuan-Sheng Zhao
Jun 22, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhe-Yi HuCheng Guo
Jul 7, 2010·Pharmacogenomics·Sharon Marsh, Janelle M Hoskins
Feb 5, 2014·Pharmacogenetics and Genomics·Julia M BarbarinoRuss B Altman
Mar 13, 2014·The Journal of Clinical Investigation·Ralph StadhoudersEric Soler
Jun 13, 2014·Clinical Pharmacology and Therapeutics·C GuillemetteM Rouleau
Jun 25, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federico InnocentiMark J Ratain

❮ Previous
Next ❯

Citations

Aug 17, 2016·British Journal of Clinical Pharmacology·Ana Beatriz SantoroGuilherme Suarez-Kurtz
Nov 1, 2017·World Journal of Gastroenterology : WJG·Diego MarquesVivian Nogueira Silbiger
Dec 29, 2019·International Journal of Molecular Sciences·Alessandro MicarelliMarco Alessandrini
Nov 25, 2020·Journal of Personalized Medicine·Ana Rita SimõesÁngel Carracedo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.